Weekly Heart Health News

First AI-generated drug

Yasmine S. Ali, MD
July 19, 2023

Welcome to your weekly dose of heart-health news! I’ve been wanting to stay in touch more frequently with all my Speak for the Heart newsletter subscribers, so I’m excited to offer this new feature!

I plan to send out this weekly update every Wednesday, except for the final Wednesday of the month, when the long magazine-style version of Speak for the Heart will be delivered to your inbox!

For my premium subscribers, each of these weekly updates will also feature my take on each recommended news article, so you can have an idea of what each bit of heart-health news means “in real life.”

Not a premium subscriber? You can upgrade now:

To your health,

Yasmine S. Ali, MD

Weekly Heart-Health News: The Highlights

First drug developed by generative AI administered to patients - UPI.com

Insilico Medicine, a biotechnology company based in Hong Kong, announced that human patients have begun receiving the drug INS018_055, an anti-fibrotic small molecule inhibitor.

www.upi.com/Science_News/2023/07/02/insilico-medicine-ai-developed-drug/4621688332959

My Take (Analysis Visible to Premium Subscribers Only)

Anesthesiologists warn: Stop taking Ozempic, Wegovy before surgery - UPI.com

The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.

www.upi.com/Health_News/2023/07/03/Ozempic-Wegovy-anesthesia-warning/9831688410910

My Take (Premium Only)

Heart health: The role played by gut bacteria

Researchers say certain bacteria in the gut may be linked to increased plaque in the arteries as well as other cardiovascular conditions

www.medicalnewstoday.com/articles/gut-bacteria-can-increase-plaque-buildup-in-heart-arteries#The-importance-of-gut-bacteria-research